Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.
Technology - Micron Biomedical
Micron Waste Secures US Biotech Patent
In the News - Micron Biomedical
LTS and Micron announce collaboration for commercial manufacturing of MAP technology
BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific
2015 Startups to Watch Award
2款微针疫苗接连步入临床,Micron Biomedical为何令盖茨基金会“青眼有
Micron Biomedical, Inc. Overview
Microdermics - Products, Competitors, Financials, Employees